COURSE CREDITS & HOURS16 AMA PRA Category 1 Credits™
16 ACPE Credits
12 hours live lecture + 4 hours "flipped classroom"
COURSE FEES$995 for Physicians, Attorneys, Psychologists, Pharmacists, & Dentists
- The Evoluation Of Cervical Cancer Screening
- The healthcare provider will recognize the development of modern day cervical cancer screening, the role of high risk HPV in male and female lower genital tract, oropharyngeal, anal carcinogenesis, and the importance of promoting HPV vaccination
- Bridging The Perimenopausal Gap Without Estrogen
- The clinician will address the concerns of perimenopausal women including their complaints of mood disturbance, vasomotor symptoms, insomnia, diminished sexual desire, vaginal atrophy
- The clinician will offer patients a variety of behavioral, hormonal, nonhormonal therapeutic modalities during this perimenopausal window.
- The Adnexal Mass
- The provider will describe the new model of ovarian carcinogenesis and the obstacles encountered in trying to develop ovarian cancer screening.
- The participant will assess the malignant potential of a palpable mass in a woman using present day imaging and ovarian tumor markers and direct appropriate conservative, medical, or surgical intervention.
- The Evaluation and Treatment of Female Urinary Incontinence
- Attendees will differentiate the types of female urinary incontinence and provide appropriate counseling on causes and treatment options available including behavioral modification, pelvic floor rehabilitation, drug therapy and urogynecological/neurological referral.
- The Overactive Bladder
- Participants will diagnose overactive bladder according to the 2014 Guidelines of the American Urological Association and prescribe a step-wise treatment plan for his/her patients with this disorder.
- The PCOS Look-Alikes
- Participants will generate a differential diagnosis for females of various reproductive ages presenting with signs of hyperandrogenism and order appropriate laboratory, radiologic imaging and timely referral to an endocrinologist, gynecologic oncologist, or general surgeon.
- Polycystic Ovary Syndrome
- li>Upon completion of this didactic activity, the attendee will identify patients with PCOS, initiate recommended metabolic screening endorsed by the 2013 Endocrine Society and employ treatment for signs of hyperandrogenism.
- The participant will also prescribe risk reducing behavioral and pharmacotherapeutic measures for long term sequela of this disorder.
- The Burning Vulva Syndrome
- The participant will give examples of the variety of infectious, inflammatory, neoplastic, and neurologic disorders that cause vulvar burning/ pruritus, and make timely decisions on proper treatment and need for biopsy.
- Managements Of The Pesky Vaginal Discharge
- The participant will draw from historical and physical exam findings, culture and new quantitative PCR based assays to properly detect and treat a variety of recurrent infectious and non-infectious causes of vaginal irritative symptoms.
- Female Sexual Concerns
- The attendee will openly discuss problems of a sexual nature with his/her patients, define the type of sexual dysfunction and offer behavioral, pharmacologic therapy or referral to sex therapist
- Reclassifying Abnormal Uterine Bleeding and the Role of Endometrial Biopsy
- Attendees will adopt the PALM-COEIN classification system in defining the etiology of abnormal uterine bleeding in a nonpregnant woman of reproductive age. Additionally, participants will be able to select the most appropriate and cost effective imaging studies to confirm a specific disorder and direct endometrial biopsy based on patient specific risk factors.
- The provider will recognize the potential role of new GnRH receptor antagonists, selective progesterone receptor modulators and the levonorgestrel-IUD in treating AUB-L
- Whats New with Fibroids?
- With newly acquired insight as to the various pharmacologic agents including GnRH agonists/antagonists, tranexamic acid, the levonorgestrel-IUD, selective progesterone receptor modulators, and radiologic interventions such as uterine artery embolization and MRI-guided Focused Ultrasound Surgery, available for symptomatic uterine fibroids, the participant of this CME will select the most appropriate management to meet the individual needs of his/her patients.
Conference Sessions generally take place on days at sea (as itinerary allows), giving you plenty of time to enjoy your meals, evenings and ports of call with your companion, family and friends.